Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - SurModics, Inc. (NasdaqNM:SRDX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
9924 West 74th Street
Eden Prairie, MN 55344
Phone: (952) 829-2700
Fax: (952) 829-6743
Email: info@surmodics.com
Employees (last reported count): 118
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Basic Materials
 ·Industry: Chemical Manufacturing
Company Websites
 ·Home Page
 ·Investor Relations
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 22%
·Over the last 6 months:
 · 3 insider sells; 16.0K shares
  (0.4% of insider shares)
·Institutional: 39% (50% of float)
(152 institutions)
·Net Inst. Buying: 1.26M shares (+16.20%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
SurModics, Inc. is a provider of surface modification solutions to the medical device industry. The Company's primary focus is the commercialization of its patented PhotoLink process through third-party licensing arrangements. PhotoLink is a versatile, easily applied, light-activated coating technology that modifies medical device surfaces by treating covalent bonds between those surfaces and a variety of chemical agents. Through the PhotoLink process, these chemical agents can impart many performance-enhancing characteristics, such as lubricity, hemocompatibility, infection resistance and drug incorporation, onto the surface of a medical device without materially changing the dimensions or physical properties of the device.
More from Market Guide: Expanded Business Description

Financial Summary
SurModics provides surface modification solutions to the medical device industry; the Company's primary focus is the commercialization of its patented PhotoLink process through licensing agreements. For the nine months ended 6/30/01, total revenues rose 24% to $15.8 million. Net income rose 68% to $4.6 million. Revenues reflect genomics work with Motorola and work on Johnson and Johnson's drug delivery stent program. Net income also reflects higher cash and investment balances.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Dale Olseth, 70
Chairman, CEO
$200K--  
James Powell, 51
Pres and COO
181K$506K
Stephen Hathaway, 45
CFO, VP
151K140K
Patrick Guire, Ph.D., 64
Sr. VP of Research and CSO
130K308K
Walter Diers, Jr., 49
VP of Corp. Devel.
143K244K
Dollar amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:SRDXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Nov-2000
$19.75 
Recent Price$46.60 
52-Week High
on 25-June-2001
$60.30 
Beta1.31 
Daily Volume (3-month avg)189.5K
Daily Volume (10-day avg)207.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change+92.9%
52-Week Change
relative to S&P500
+158.8%
Share-Related Items
Market Capitalization$780.4M
Shares Outstanding16.7M
Float13.1M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 7-Dec-2000
Per-Share Data
Book Value (mrq)$3.18 
Earnings (ttm)$0.34 
Earnings (mrq)$0.09 
Sales (ttm)$1.21 
Cash (mrq)$0.84 
Valuation Ratios
Price/Book (mrq)14.65 
Price/Earnings (ttm)135.86 
Price/Sales (ttm)38.66 
Income Statements
Sales (ttm)$21.4M
EBITDA (ttm)$8.27M
Income available to common (ttm)$6.08M
Profitability
Profit Margin (ttm)28.5%
Operating Margin (ttm)31.3%
Fiscal Year
Fiscal Year EndsSep 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)12.19%
Return on Equity (ttm)12.84%
Financial Strength
Current Ratio (mrq)5.33 
Debt/Equity (mrq)0 
Total Cash (mrq)$14.1M
Short Interest
As of 8-Aug-2001
Shares Short786.0K
Percent of Float6.0%
Shares Short
(Prior Month)
411.0K
Short Ratio6.14 
Daily Volume128.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.